Aspirin And Caffeine

Toothache, Chronic Pain, Muscle Pain + 59 more
Treatment
6 FDA approvals
20 Active Studies for Aspirin And Caffeine

What is Aspirin And Caffeine

AcetaminophenThe Generic name of this drug
Treatment SummaryCaffeine is a drug used to treat a number of medical conditions, including respiratory problems in premature babies, pain relief, and drowsiness. Caffeine can be found in coffee beans, teas, and cacao beans. It is also used in various cosmetic products, and can be taken orally, by inhalation, topically, or through injection. In 1999, the FDA approved caffeine citrate injection for apnea of the premature newborn. Caffeine has been shown to be beneficial in preventing and treating apnea and bronchopulmonary dysplasia in premature infants, giving them a better quality of life.
TYLENOL Extra Strengthis the brand name
image of different drug pills on a surface
Aspirin And Caffeine Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
TYLENOL Extra Strength
Acetaminophen
1950
2371

Approved as Treatment by the FDA

Acetaminophen, also called TYLENOL Extra Strength, is approved by the FDA for 6 uses including Pain and Pain .
Pain
Pain
Used in combination with Acetaminophen / Codeine for moderate Pain
Chronic Pain
Opioids
Pain
Mild pain
Used in combination with Acetaminophen / Codeine for Mild pain

Effectiveness

How Aspirin And Caffeine Affects PatientsCaffeine increases alertness, and can cause jitteriness and excitability. It also relaxes the muscles in the body, increases the strength of heart contractions, and improves athletic performance. Caffeine can also make the stomach produce more acid and make the digestive system work faster. It is often taken with painkillers or other medications to help relieve migraine headaches. Lastly, caffeine acts as a mild diuretic, which means it encourages the body to get rid of more liquid.
How Aspirin And Caffeine works in the bodyCaffeine affects many body systems in multiple ways. Generally, it prevents the breakdown of molecules that regulate cell function, blocks adenosine receptors, and raises oxygen consumption. In the respiratory system, caffeine stimulates the respiratory center in the brain and increases responsiveness to carbon dioxide. In the central nervous system, it blocks adenosine receptors and keeps you alert. In the renal system, it causes increased urination. And in the cardiovascular system, it increases heart rate and blood pressure, while also causing vasodilation in the blood vessels. Caffeine is also used to treat headaches, which is thought to be due to its vasocon

When to interrupt dosage

The endorsed dosage of Aspirin And Caffeine is contingent upon the determined affliction, comprising Overdose, Drug, Catarrh and Athletic Performance. The quantity of dosage can be found in the table below, contingent upon the technique of delivery (e.g. Tablet or Tablet - Oral).
Condition
Dosage
Administration
Toothache
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Chronic Pain
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Muscle Pain
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Chills
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Catarrh
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Trigeminal Neuralgia
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Collagen Diseases
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Acute Bronchitis
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Sinusitis
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Dysmenorrhea
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Migraine
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Muscle Cramp
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Arthritis, Gouty
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Rhinorrhea
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Pain
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Common Cold
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Fever
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Spasm
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Analgesics
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous
Spasm
, 32.0 mg/mL, 325.0 mg, 160.0 mg/mL, 65.0 mg/mL, 32.5 mg/mL, 1000.0 mg, 650.0 mg, 500.0 mg, 250.0 mg, 50.0 mg/mL, 30.0 mg/mL, 800.0 mg/mL, 0.065 mg/mg, 167.0 mg/mL, 163.0 mg/mL, 160.0 mg, 100.0 mg/mL, 120.0 mg, 750.0 mg, 660.0 mg, 300.0 mg, 80.0 mg, 200.0 mg, 110.0 mg, 325.0 mg/mL, 120.0 mg/mL, 500.0 mg/mL, 3.25 mg/mL, 0.02 mg/mg, 0.1 mg/mg, 400.0 mg, 320.5 mg, 250.0 mg/mL, 5.0 mg/mg, 162.5 mg, 1.625 mg/mg, 105.0 mg, 50.0 mg, 6.75 mg/mL, 25.0 mg/mL, 20.0 mg/mL, 1.0 mg/mg, 712.8 mg, 60.0 mg, 0.8 mL/mL, 80.0 mg/mL, 260.0 mg, 100.0 mg, 0.05 mg/mg, 3.249 mg/mg, 5.004 mg/mg, 250.0 mg/mg, 0.25 mg, 350.0 mg, 600.0 mg, 90.0 mg, 64.0 mg/mL, 2.0 mg/mg, 194.0 mg, 0.65 mg/mg, 325.0 mg/mg, 10.0 mg/mL, 650.0 mg/mL, 162.0 mg, 21.7 mg/mL, 125.0 mg, 115.0 mg, 130.0 mg, 0.08 mg/mg, 0.5 mg/mg, 1.6 mg/mL, 150.0 mg, 200.0 mg/mL, 0.5 mg, 16.25 mg/mL, 320.0 mg/mL, 235.0 mg, 1300.0 mg, 300.0 mg/mL, 108.0 mg/mL, 180.0 mg, 130.0 mg/mL, 1150.0 mg, 0.325 mg/mg, 36.0 mg/mL, 24.0 mg/mL, 33.33 mg/mL, 82.5 mg/mL, 21.667 mg/mL, 0.07 mg/mg, 43.334 mg/mL, 500.0 mg/units, 16.0 mg/mL, 0.0325 mg/mg, 65.0 mg/mg, 5.0 mg/mL, 6.5 mg/mL, 11.5 mg/mL, 67.5 mg/mL, 352.0 mg
Oral, Tablet, Liquid, Tablet, film coated - Oral, Capsule - Oral, Powder, for solution, , Tablet, chewable, Liquid - Oral, Tablet - Oral, Tablet, extended release - Oral, Syrup, Capsule, gelatin coated, Kit, Tablet, coated, Tablet, coated - Oral, Capsule, coated, Solution, Capsule, coated - Oral, Capsule, liquid filled, Tablet, chewable - Oral, Capsule, Tablet, film coated, Powder - Oral, Powder, Kit; Tablet - Oral, Topical, Tablet, film coated, extended release - Oral, Granule, Capsule, delayed release pellets, Capsule, gelatin coated - Oral, Solution - Oral, Powder, for solution - Oral, Kit - Oral, Tablet, delayed release, Tablet, orally disintegrating - Oral, Syrup - Oral, Tablet, multilayer - Oral, Injection, Ophthalmic; Oral; Topical, Suspension - Oral, Kit; Powder, Nasal; Oral, Suspension, Solution / drops - Oral, Solution - Intravenous, Tablet, effervescent, Granule, for solution, Granule, for solution - Oral, Capsule, liquid filled - Oral, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, effervescent - Oral, Kit - Oral; Respiratory (inhalation); Topical, Powder, for suspension, Powder, for suspension - Oral, Granule, effervescent, Granule, effervescent - Oral, Kit - Ophthalmic; Oral; Topical, Suppository, Suppository - Rectal, Rectal, Tablet, extended release, Oral; Topical, Kit - Oral; Topical, Tablet, delayed release - Oral, Tablet, film coated, extended release, Kit - Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Suspension / drops, Kit; Powder - Oral, Tablet, orally disintegrating, Granule - Oral, Elixir - Oral, Tablet, film coated - Topical, Tablet, multilayer, Elixir, Capsule, delayed release pellets - Oral, Kit; Tablet, Intravenous, Capsule; Kit, Capsule; Kit - Oral, Suspension / drops - Oral, Solution / drops, Liquid; Solution / drops, Liquid; Solution / drops - Oral, Kit; Powder, for solution - Oral, Kit; Powder, for solution, Liquid - Topical, Oral; Respiratory (inhalation); Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Injection, solution - Intravenous, Injection, solution, Bar, chewable, Nasal, Bar, chewable - Oral, Injection - Intravenous

Warnings

Aspirin And Caffeine has a single contraindication and should not be consumed simultaneously with any of the conditions given in the following table.Aspirin And Caffeine Contraindications
Condition
Risk Level
Notes
Severe Hepatic Impairment
Do Not Combine
Liver diseases
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Acetaminophen may interact with Pulse Frequency
There are 20 known major drug interactions with Aspirin And Caffeine.
Common Aspirin And Caffeine Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Acetaminophen.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Acetaminophen.
Alectinib
Major
The metabolism of Alectinib can be increased when combined with Acetaminophen.
Alpelisib
Major
The metabolism of Alpelisib can be increased when combined with Acetaminophen.
Amitriptyline
Major
The metabolism of Amitriptyline can be decreased when combined with Acetaminophen.
Aspirin And Caffeine Toxicity & Overdose RiskCaffeine overdose in rats has been found to be toxic at 192mg/kg. For humans, consuming 10-14 grams (150-200mg/kg) could be fatal. Symptoms of an overdose may include nausea, vomiting, diarrhea, restlessness, anxiety, insomnia, increased heart rate, tremors, and psychomotor agitation. In extreme cases, death could occur. If someone has overdosed on caffeine, treatment may involve offering supportive care, intubating for airway protection, administering activated charcoal and hemodialysis, giving benzodiazepines to prevent or treat seizures, providing IV fluids and vasopress
image of a doctor in a lab doing drug, clinical research

Aspirin And Caffeine Novel Uses: Which Conditions Have a Clinical Trial Featuring Aspirin And Caffeine?

Currently, 429 active clinical trials are investigating the possibility of Aspirin and Caffeine to provide relief from Chronic Fatigue Syndrome, Chronic Pain and Migraine Headaches.
Condition
Clinical Trials
Trial Phases
Spasm
0 Actively Recruiting
Mild pain
0 Actively Recruiting
Pain
0 Actively Recruiting
Inflammation
0 Actively Recruiting
Febrile Illness Acute
0 Actively Recruiting
Rheumatoid Arthritis
57 Actively Recruiting
Not Applicable, Phase 4, Phase 3, Phase 2, Phase 1
Migraine
14 Actively Recruiting
Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4
Dislocations
1 Actively Recruiting
Phase 2, Phase 3
Dysmenorrhea
1 Actively Recruiting
Not Applicable
Pain
0 Actively Recruiting
Pain
0 Actively Recruiting
Chronic Pain
134 Actively Recruiting
Not Applicable, Phase 4, Phase 2, Phase 3, Early Phase 1, Phase 1
Rhinorrhea
0 Actively Recruiting
Influenza
29 Actively Recruiting
Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3
Postoperative Pain
21 Actively Recruiting
Phase 4, Phase 2, Phase 1, Not Applicable, Early Phase 1, Phase 3
Torticollis
6 Actively Recruiting
Not Applicable, Phase 2
Opioids
6 Actively Recruiting
Phase 4, Phase 2, Not Applicable, Early Phase 1
Coughing
0 Actively Recruiting
Muscle Cramp
0 Actively Recruiting
Bronchodilation
0 Actively Recruiting

Aspirin And Caffeine Reviews: What are patients saying about Aspirin And Caffeine?

5Patient Review
10/8/2014
Aspirin And Caffeine for Migraine Headache
I've been dealing with migraines for 40 years, and Exedrin is the only thing that really works for me. It's helped me immensely over the last 15 years. Even if I take it after a migraine has already started, it still does its job. Usually the pain is gone within 30 minutes, but even when it isn't, I still feel much better.
5Patient Review
1/29/2010
Aspirin And Caffeine for Head Pain
This medication really works well on common headaches. In my opinion, it's even faster-acting than acetaminophen or ibuprofen.
5Patient Review
3/21/2010
Aspirin And Caffeine for Pain
I experienced a severe abdominal muscle strain.
4.7Patient Review
5/20/2022
Aspirin And Caffeine for Migraine Headache
Migraines, like all fits, follow the same pattern: PreDerm; Auroa; Fit; PostDermIf I took paracetamol, asparin, caffeine on PreDerm it would completely stop the fit; I'd still feel not with it for a few days though.If I took it in the first 10 minutes of Auroa I would still get the fit, but much lessened. If I was late... don't be late!
4Patient Review
12/13/2011
Aspirin And Caffeine for Migraine Headache
I've had migraines since I was five years old and usually require prescription medication to manage the pain. However, these drugs always make me nauseous. Once, when I forgot my medicine and a migraine started while at a friend's house, her mom gave me Excedrin. It worked wonders! After just a short nap, the pain was gone.
3.7Patient Review
4/13/2014
Aspirin And Caffeine for Migraine Headache
I've had migraines since I was a child. In the past, I had taken a medication which had been prescribed for my mother who also has migraines. One day I got a migraine at work. A co-worker gave me some Excedrin and amazingly, it worked. It didn't totally get rid of the pain, but at least I could function again. Ever since then, I take 2 Excedrin whenever I start to get an aura and that's usually enough to help me cope.
2.3Patient Review
8/6/2009
Aspirin And Caffeine for Migraine Headache
This medication was supposed to help control my migraines, but it only made things worse by giving me an upset stomach.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about aspirin and caffeine

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can you drink energy drinks with aspirin?

"Don't drink coffee, tea, cola, or energy drinks while taking this medication, since they contain caffeine which can intensify the medication's side effects."

Answered by AI

What should you not take aspirin with?

"It is safe to take aspirin as a painkiller with paracetamol or codeine, but one should not take aspirin with ibuprofen or naproxen without talking to a doctor. Aspirin, ibuprofen, and naproxen all belong to the same group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs)."

Answered by AI

Can you take aspirin with caffeine?

"Bayer Select Maximum Strength Headache Pain Relief Formula. Excedrin Migraine.

Caffeine and aspirin work together well to relieve certain types of headaches, such as tension headaches and migraines. Medications that contain both aspirin and caffeine include Anacin, Aspircaf, Bayer Select Maximum Strength Headache Pain Relief Formula, and Excedrin Migraine."

Answered by AI

What drug has aspirin and caffeine?

"Acetaminophen, aspirin, and caffeine can be used to treat pain caused by tension headaches, migraine headaches, muscle aches, menstrual cramps, arthritis, toothaches, the common cold, or nasal congestion."

Answered by AI

Clinical Trials for Aspirin And Caffeine

Image of California Clinical Trials Medical Group in Glendale, United States.

NTR-1011 for Lupus and Rheumatoid Arthritis

18 - 75
All Sexes
Glendale, CA
This phase 1a and 1b study is designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy of NTR-1011 in healthy adults and in adult patients with systemic lupus erythematosus and rheumatoid arthritis. The main goals of this study are to determine the safety profile of NTR-1011 across subcutaneous and intravenous dose levels, understand how the drug behaves in the body, characterize its biological activity through relevant pharmacodynamic markers, assess the potential for immune responses to treatment, and explore early signals of clinical benefit in autoimmune disease settings. This is a randomized, double blind, placebo controlled study that begins with a single ascending dose evaluation in healthy volunteers followed by a multiple dose assessment in patients. The design is intended to define the highest safe and well tolerated dose, establish a robust PK and PD baseline, and generate initial patient level evidence to support dose selection and advancement into subsequent clinical development.
Phase 1
Recruiting
California Clinical Trials Medical GroupHakop Gevorkyan, MDNeutrolis
Image of Vanderbilt University Medical Center in Nashville, United States.

Lidocaine Infusions for Postoperative Pain

18+
All Sexes
Nashville, TN
The goal of this single-center, pragmatic, randomized, blinded, placebo-controlled trial is to evaluate the impact of intravenous (IV) lidocaine within the existing Enhanced Recovery After Surgery (ERAS)program on outcomes in patients after major abdominal surgery. The main questions the trial aims to answer are: The primary hypothesis is that utilization of IV lidocaine as part of a perioperative multimodal pain regimen will result in a reduction in hospital Case Mix Index-Adjusted Resource Length of Stay (CARLOS). The secondary hypotheses are that lidocaine infusion will result in a reduction in total inpatient opioid consumption (oral morphine milligram equivalents, oMMEs) and pain scores, and improved surgical outcomes (including return of bowel function, ileus, nausea, rapid responses called, surgical site infections, and ICU transfers), while also having minimal incidence of side effects (including double/blurry vision, tinnitus, sedation, and adverse events requiring early cessation).
Phase 4
Waitlist Available
Vanderbilt University Medical CenterDanial Shams, MD
Have you considered Aspirin And Caffeine clinical trials? We made a collection of clinical trials featuring Aspirin And Caffeine, we think they might fit your search criteria.Go to Trials
Image of Baylor College of Medicine/Texas Children's Hospital in Austin, United States.

Guided Imagery Therapy for Abdominal Pain

7 - 12
All Sexes
Austin, TX
Chronic abdominal pain is common among children, and the majority of cases are attributed to functional abdominal pain disorders. One approach to treating these disorders is by using psychological therapies. This clinical trial aims to see how well pre-recorded guided imagery therapy sessions help children's abdominal pain when delivered via a mobile application (app) on a smartphone or tablet. Participants will complete a baseline abdominal pain and stooling diary to determine eligibility, as well as other surveys. Eligible participants will be given access to the guided imagery therapy mobile application. This intervention asks participants to listen to a 10- to 15-minute GIT session 5 out of 7 days per week for 8 weeks, in addition to their usual care for their abdominal pain. Then, participants will complete another abdominal pain and stooling diary, along with other psychometric surveys, at the end of this intervention period. Participants will also collect another diary and surveys 3 months post-treatment.
Waitlist Available
Has No Placebo
Baylor College of Medicine/Texas Children's Hospital (+1 Sites)
Image of Weill Cornell Medical College in New York, United States.

Health Coaching for Rheumatoid Arthritis

18+
All Sexes
New York, NY
The goal of this clinical trial is to learn if peer coaching works to reduce levels of anxiety and/or depression in adults diagnosed with Rheumatoid Arthritis (RA). The main questions it aims to answer are: Do people with RA who complete the intervention with a peer coach have lower levels of anxiety and/or depression at 6 months from baseline? Do people with RA who complete the intervention with a peer coach have lower levels of anxiety and/or depression at 6 months compared to those in the control arm? Researchers will compare the peer coaching intervention to an active-control arm (where people without RA coach participants on general health and nutrition topics) to see if peer coaching works to reduce anxiety and/or depression. Participants will meet with a coach every week for 9 weeks and complete several surveys before, during and after the intervention
Recruiting
Has No Placebo
Weill Cornell Medical CollegeIris Y Navarro-Millán, MDBristol-Myers Squibb
Image of Humana Healthcare Research, Inc. in Louisville, United States.

Academic Detailing for Rheumatoid Arthritis

Any Age
All Sexes
Louisville, KY
The goal of this trial is to learn if an interactive evidence-based educational outreach visits to clinicians who prescribe biologics change prescribing of biosimilar medications. The main questions it aims to answer are: 1. Do educational outreach visits lead to a higher number of prescriptions for biosimilar versions of adalimumab? 2. Do in-person or virtual visits work better? Researchers will compare clinicians offered the educational outreach visit to those who are not offered the visit to see if there is a difference in prescribing of biosimilar versions of adalimumab instead of the original brand-name version. Participants will be offered the chance to meet with a trained clinician who will provide educational information tailored to their knowledge and attitudes on the topic. They will also be provided an educational brochure and patient educational materials.
Waitlist Available
Has No Placebo
Humana Healthcare Research, Inc. (+1 Sites)
Have you considered Aspirin And Caffeine clinical trials? We made a collection of clinical trials featuring Aspirin And Caffeine, we think they might fit your search criteria.Go to Trials
Image of University of California, Los Angeles in Los Angeles, United States.

Emotional Awareness and Expression Therapy for Chronic Pain

18+
All Sexes
Los Angeles, CA
About one in three Veterans lives with long-term (chronic) pain, and many of them also struggle with past trauma and mental health issues like depression, anxiety, or PTSD. Emotional Awareness and Expression Therapy (EAET) is a type of talk therapy that helps people understand and express their emotions, especially those linked to past trauma. This therapy has been shown to help reduce pain and improve mental health. So far, multiple studies have tested EAET in both Veterans and civilians, and the results have been promising. EAET has helped people feel less pain, move better, and experience fewer mental health symptoms. Because of these strong results, the U.S. Department of Health \& Human Services named EAET a Best Practice for managing pain in 2019. Two earlier studies at a VA hospital in Los Angeles found that EAET worked even better than another well-known therapy called cognitive behavioral therapy for chronic pain (CBT-CP) for older Veterans. However, those studies were done in tightly controlled settings. Now, researchers want to see if EAET works just as well when it's used in everyday healthcare settings, by different types of doctors and therapists. This new project will happen in two parts, but we will only focus on the first part in this entry: In the first part (a 1-year phase), doctors and therapists at up to 7 VA hospitals across the country will be trained to use EAET. They will then try it out with Veterans to see how well it works and how easy it is to use in real clinics. Veterans, doctors, and other staff will be asked for feedback to learn what helps or gets in the way of using EAET.
Waitlist Available
Has No Placebo
University of California, Los Angeles
Image of National Institutes of Health Clinical Center in Bethesda, United States.

BPL-1357 for Flu

18 - 55
All Sexes
Bethesda, MD
Background: Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from it. Current vaccines protect against seasonal flus, but broader vaccines are needed to protect against potential flu pandemics. Objective: To test an experimental flu vaccine. Eligibility: Healthy people aged 18 to 55 years. Design: The study will last 5 to 8 months and has 2 phases, A and B. The study vaccine will be given either as a shot in the arm or as a nasal spray. Participants will receive 1 of 3 combinations: (1) study vaccine in the nose and placebo in the arm; (2) placebo in the nose and study vaccine in the arm; or (3) placebo in the nose and placebo in the arm. A placebo is just like the real vaccine but contains no active ingredients. Phase A: Participants will have 5 clinic visits over 56 days. They will receive a shot and a nasal spray at 2 of the visits, 28 days apart. At each visit, they will have a physical exam, with tests of their blood, urine, and nasal secretions. They will check their temperature at home and record any symptoms for 7 days after each vaccine. Phase B: Participants will stay in the hospital for at least 9 days. They will be infected with a flu virus. They will provide blood, urine, and nasal fluid samples. They will have tests of their heart function. They will remain in the hospital until they test negative for the flu 2 days in a row. They will have 2 follow-up visits, 4 and 8 weeks after leaving the hospital.
Phase 2
Waitlist Available
National Institutes of Health Clinical Center (+1 Sites)Luca T Giurgea, M.D.
Image of Vanderbilt University Medical Center in Nashville, United States.

High vs. Standard Dose Influenza Vaccines for Flu

18+
All Sexes
Nashville, TN
This will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-0014) at Vanderbilt University Medical Center. Lung transplantation is a life-saving therapy for patients with advanced lung disease, and is also associated with an improvement in quality of life. However, due to the need for life-long immunosuppression to prevent acute cellular rejection and chronic lung allograft dysfunction ("chronic rejection"), lung transplant recipients are at risk for developing major infections. In fact, one-year survival is 85%, with infection being the leading cause of death within the first year post-transplant. We will conduct a follow-up phase II, randomized, double-blind trial to assess the impact of subsequent administration of two doses of HD-IIV compared to two doses of SD-IIV among lung recipients during the early post-transplant period. Demonstration of improved immunogenicity from two doses of HD-IIV over consecutive influenza seasons would provide potential broad benefit in reducing influenza disease and its associated complications in lung transplant recipients. Moreover, studying vaccine immunogenicity and safety in the same participants over consecutive years can provide insight into the influence of immunosuppression levels and allograft aging on vaccine-mediated immune modulation. This proposed study design will contribute significantly to influenza vaccination guidance and policy for the highly vulnerable lung transplant population. This proposed study is designed to address several key knowledge gaps in vaccine-mediated protection of lung transplant recipients against influenza: * Is there increased immunogenicity with administration of one or two doses of HD-IIV or SD-IIV in the subsequent season compared to two doses of HD-IIV or SD-IIV in the first season? * What is the durability of the humoral and cellular immune response between influenza seasons and does two doses of HD-IIV or SD-IIV sustain higher HAI titers compared to two doses of HD-IIV or SD-IIV in the first season? * What is the impact of maintenance immunosuppression levels on influenza vaccine immunogenicity within the same participant? * Will the optimal immunogenic vaccination strategy be associated with an acceptable long-term safety profile over successive influenza seasons, including injection-site and systemic reactions, allosensitization, and organ rejection?
Phase 2
Recruiting
Vanderbilt University Medical CenterNatahsa Halasa, MD, MPH
Have you considered Aspirin And Caffeine clinical trials? We made a collection of clinical trials featuring Aspirin And Caffeine, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security